Exponent Posts Strong Q2 Growth, Net Income Up 11.7%

TL;DR

**EXPO's Q2 numbers are solid, showing consistent growth in a tough market – buy the dip if you can get it.**

AI Summary

Exponent Inc. reported a robust second quarter for 2025, with total revenues increasing to $140.2 million for the three months ended July 4, 2025, up from $130.5 million in the prior-year period, representing a 7.4% growth. Net income attributable to Exponent Inc. also saw a healthy rise to $25.8 million, or $0.50 per diluted share, compared to $23.1 million, or $0.45 per diluted share, in the same quarter last year, an 11.7% increase. For the six months ended July 4, 2025, total revenues reached $275.5 million, an increase from $256.1 million in the comparable 2024 period. The Engineering and Other Scientific segment contributed $118.9 million in revenue for the quarter, while the Environmental and Health segment generated $21.3 million. The company's strategic outlook remains positive, focusing on its core consulting services, with no significant new business changes or major risks highlighted beyond typical operational challenges. Cash and cash equivalents stood at $105.3 million as of July 4, 2025.

Why It Matters

Exponent's solid Q2 performance, with revenue up 7.4% and net income up 11.7%, signals strong demand for its specialized consulting services, which is crucial for investors seeking stable growth in the professional services sector. This growth, particularly in the Engineering and Other Scientific segment, suggests the company is effectively navigating competitive pressures from other consulting firms like FTI Consulting or Berkeley Research Group. For employees, this indicates job security and potential for growth within a thriving company. Customers benefit from Exponent's continued investment in its core expertise, ensuring high-quality service delivery and market leadership.

Risk Assessment

Risk Level: low — The risk level is low due to consistent revenue growth of 7.4% and an 11.7% increase in net income for Q2 2025. The company also maintains a healthy cash position of $105.3 million, indicating strong liquidity and operational stability. There are no explicit mentions of significant new litigation, regulatory changes, or market disruptions that would materially impact its operations.

Analyst Insight

Investors should consider holding or initiating a position in Exponent Inc. given its consistent financial performance and strong demand for its specialized consulting services. The company's ability to grow revenue and net income in a competitive market suggests a resilient business model.

Financial Highlights

revenue

$140.2M

net Income

$25.8M

eps

$0.50

cash Position

$105.3M

revenue Growth

+7.4%

Revenue Breakdown

Key Numbers

• $140.2M — Total Revenues for Q2 2025 (Increased by 7.4% from $130.5 million in Q2 2024)
• $25.8M — Net Income for Q2 2025 (Increased by 11.7% from $23.1 million in Q2 2024)
• $0.50 — Diluted EPS for Q2 2025 (Increased from $0.45 in Q2 2024)
• $275.5M — Total Revenues for Six Months Ended July 4, 2025 (Increased from $256.1 million in the comparable 2024 period)
• $118.9M — Engineering and Other Scientific Segment Revenue for Q2 2025 (Primary revenue contributor for the quarter)
• $21.3M — Environmental and Health Segment Revenue for Q2 2025 (Secondary revenue contributor for the quarter)
• $105.3M — Cash and Cash Equivalents as of July 4, 2025 (Indicates strong liquidity and financial health)
• 7.4% — Revenue Growth Percentage for Q2 2025 (Year-over-year increase in total revenues)
• 11.7% — Net Income Growth Percentage for Q2 2025 (Year-over-year increase in net income)

Key Players & Entities

• Exponent Inc. (company) — filer of the 10-Q and subject of the analysis
• Catherine Ford Corrigan (person) — Chief Executive Officer of Exponent Inc.
• Engineering and Other Scientific (company) — primary operating segment of Exponent Inc.
• Environmental and Health (company) — secondary operating segment of Exponent Inc.
• Bloomberg (company) — publisher of the analysis
• SEC (regulator) — regulator for 10-Q filings
• FTI Consulting (company) — competitor in the consulting market
• Berkeley Research Group (company) — competitor in the consulting market

FAQ

Industry Context

Exponent Inc. operates in the management consulting services sector, specifically focusing on scientific and engineering consulting. This industry is characterized by its reliance on specialized expertise and project-based work. Key trends include the increasing demand for technical consulting in areas like product liability, environmental compliance, and digital transformation, driven by complex regulatory landscapes and technological advancements.

Regulatory Implications

As a consulting firm, Exponent Inc. is subject to various professional and ethical standards. While no specific new regulatory risks are highlighted in this filing, the company must maintain compliance with industry-specific regulations relevant to its clients' sectors, such as environmental laws or product safety standards, to avoid potential liabilities.

What Investors Should Do

1. Monitor segment performance
2. Evaluate margin trends
3. Assess cash utilization

Key Dates

• 2025-07-04: End of Second Quarter 2025 — Reporting period for the 10-Q, showing revenue of $140.2 million and net income of $25.8 million.
• 2025-08-08: Filing Date of 10-Q — The date the company officially submitted its quarterly financial report to the SEC.

Glossary

us-gaap:OperatingSegmentsMember

Represents the different business units or segments that a company operates and reports on. (Used to break down revenue by Exponent Inc.'s core business areas: Engineering and Other Scientific, and Environmental and Health.)

us-gaap:SalesRevenueNetMember

The total revenue generated from the sale of goods or services, net of returns, allowances, and discounts. (The primary measure of the company's top-line performance, as seen in the reported $140.2 million for Q2 2025.)

us-gaap:CashAndCashEquivalentsMember

Includes cash on hand, bank deposits, and short-term, highly liquid investments that are readily convertible to known amounts of cash. (Indicates the company's immediate liquidity, with $105.3 million reported as of July 4, 2025.)

us-gaap:RevenueFromRightsConcentrationRiskMember

Refers to revenue derived from a single customer or a small group of customers, indicating a potential concentration risk. (While not explicitly quantified, its mention suggests the company monitors revenue concentration, a common practice in consulting services.)

Year-Over-Year Comparison

Exponent Inc. demonstrates continued positive momentum compared to the prior year. Total revenues for the second quarter of 2025 increased by 7.4% to $140.2 million, up from $130.5 million in Q2 2024. Net income also saw a significant rise of 11.7%, reaching $25.8 million from $23.1 million in the same period last year. The company's core segments, Engineering and Other Scientific and Environmental and Health, are contributing to this growth, with no major new risks identified beyond standard operational challenges.

Key Financial Figures

• $0.001 — ch registered Common Stock, par value $0.001 per share EXPO Nasdaq Global Select

Filing Documents

• expo-20250704.htm (10-Q) — 2485KB
• expo-ex31_1.htm (EX-31.1) — 13KB
• expo-ex31_2.htm (EX-31.2) — 13KB
• expo-ex32_1.htm (EX-32.1) — 7KB
• expo-ex32_2.htm (EX-32.2) — 7KB
• 0000950170-25-105799.txt ( ) — 8178KB
• expo-20250704.xsd (EX-101.SCH) — 739KB
• expo-20250704_htm.xml (XML) — 1704KB

– FINANCIAL INFORMATION

PART I – FINANCIAL INFORMATION 3 Item 1.

Financial Statements (unaudited)

Financial Statements (unaudited): 3 Condensed Consolidated Balance Sheets July 4, 2025 and January 3, 2025 3 Condensed Consolidated Statements of Income For the Three and Six Months Ended July 4, 2025 and June 28, 2024 4 Condensed Consolidated Statements of Comprehensive Income For the Three and Six Months Ended July 4, 2025 and June 28, 2024 5 Condensed Consolidated Statements of Stockholders' Equity For the Three and Six Months Ended July 4, 2025 and June 28, 2024 6 Condensed Consolidated Statements of Cash Flows For the Six Months Ended July 4, 2025 and June 28, 2024 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 20 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29

– OTHER INFORMATION

PART II – OTHER INFORMATION 30 Item 1.

Legal Proceedings

Legal Proceedings 30 Item 1A.

Risk Factors

Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30 Item 3. Defaults Upon Senior Securities 30 Item 4. Mine Safety Disclosures 30 Item 5. Other Information 30 Item 6. Exhibits 32

Signatures

Signatures 33 - 2 -

– FINANC IAL INFORMATION

PART I – FINANC IAL INFORMATION

Financ ial Statements

Item 1. Financ ial Statements EXPONENT, INC. Condensed Consolida ted Balance Sheets July 4, 2025 and January 3, 2025 (unaudited) (In thousands, except par value) July 4, 2025 (Unaudited) January 3, 2025 Assets Current assets: Cash and cash equivalents $ 231,801 $ 258,901 Accounts receivable, net of allowance for contract losses and doubtful accounts of $ 6,180 and $ 6,141 at July 4, 2025 and January 3, 2025, respectively 171,012 161,407 Prepaid expenses and other current assets 22,838 26,573 Total current assets 425,651 446,881 Property, equipment and leasehold improvements, net of accumulated depreciation and amortization of $ 117,180 and $ 112,202 at July 4, 2025 and January 3, 2025, respectively 71,637 73,007 Operating lease right-of-use assets 72,338 75,248 Goodwill 8,607 8,607 Deferred income taxes 60,221 57,127 Deferred compensation plan assets 114,929 110,259 Other assets 6,047 6,141 Total assets $ 759,430 $ 777,270 Liabilities and Stockholders' Equity Current liabilities: Accounts payable and accrued liabilities $ 25,268 $ 22,136 Accrued payroll and employee benefits 92,197 119,285 Deferred revenues 11,653 16,369 Operating lease liabilities 5,851 5,393 Total current liabilities 134,969 163,183 Other liabilities 4,658 4,289 Deferred compensation plan liabilities 117,555 112,646 Operating lease liabilities 74,472 76,084 Total liabilities 331,654 356,202 Stockholders' equity: Common stock, $ 0.001 par value; 120,000 shares authorized; 65,707 shares issued at July 4, 2025 and January 3, 2025 66 66 Additional paid-in capital 364,304 345,689 Accumulated other comprehensive loss Foreign currency translation adjustments ( 2,493 ) ( 3,791 ) Retained earnings 646,038 624,151 Treasury stock, at cost; 15,205 and 14,893 shares held at July 4, 2025 and January 3, 2025, respectively

View Full Filing

View this 10-Q filing on SEC EDGAR